These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37610033)

  • 1. Application of The Paris System in neobladder washing cytology: Comparison between the original diagnosis and correlation with histopathology.
    Kim JM; Lee J; Sung SH
    Diagn Cytopathol; 2023 Dec; 51(12):744-750. PubMed ID: 37610033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.
    Khajir G; Sun T; Wang H; Sprenkle PC; Adeniran AJ; Cai G; Levi AW
    Cytopathology; 2024 Mar; 35(2):235-241. PubMed ID: 37916579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology.
    Miyai K; Nakayama M; Minabe S; Ogata S; Ito K; Matsukuma S
    Cancer Cytopathol; 2024 Apr; 132(4):242-249. PubMed ID: 38294961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyto-histo correlation and false-negative urine: Before and after the Paris system for reporting urinary cytology.
    Yuan L; Gero M; Zia S; Aryal SC; Shetty S; Reynolds JP
    Diagn Cytopathol; 2022 Aug; 50(8):404-410. PubMed ID: 35652594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
    Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
    Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of The Paris System (TPS) for upper urinary tract cytopathology: correlation with histology follow-up and UroVysion fluorescence in situ hybridization (FISH) analysis.
    Jia L; Rood T; Kirkpatrick J; Sarode V
    J Am Soc Cytopathol; 2024; 13(2):149-155. PubMed ID: 38341300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytohistologic correlation of recurrent urothelial carcinoma detected in urinary diversion specimens.
    Xing J; Roy S; Monaco SE; Pantanowitz L
    Cancer Cytopathol; 2017 Feb; 125(2):120-127. PubMed ID: 27741389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reclassification of urinary cytology regarding The Paris System for Reporting Urinary Cytology with cytohistological correlation demonstrates high sensitivity for high-grade urothelial carcinoma.
    Anbardar MH; Monjazeb R
    Diagn Cytopathol; 2020 May; 48(5):446-452. PubMed ID: 31976626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Paris System for reporting urinary cytology improves the negative predictive value of high-grade urothelial carcinoma.
    Yamasaki M; Taoka R; Katakura K; Matsunaga T; Kani N; Honda T; Harada S; Tohi Y; Matsuoka Y; Kato T; Okazoe H; Tsunemori H; Ueda N; Haba R; Sugimoto M
    BMC Urol; 2022 Apr; 22(1):51. PubMed ID: 35382830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine cytology findings in patients with biopsy-confirmed urothelial carcinoma in situ with plasmacytoid features.
    Nichols MM; Reynolds JP; McKenney JK; Nicolas MM; McIntire PJ; Policarpio-Nicolas MLC
    Cancer Cytopathol; 2021 Oct; 129(10):798-804. PubMed ID: 33900681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the Paris system for reporting urinary cytology with histologic follow-up.
    Rohra P; Ocampo Gonzalez FA; Yan L; Mir F; Furlan K; Basu S; Barua A; Cheng L; Park JW
    Diagn Cytopathol; 2021 Jun; 49(6):691-699. PubMed ID: 33600080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A real-world study of the clinical application of the Paris system for reporting urinary cytology in cancer hospital].
    Zhao H; Zhang ZH; Guo HQ; Wei N; Ma HY; Zhao LL; Sun Y; Wang C; Chang XX; Bi XG; Xing NZ
    Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):703-709. PubMed ID: 39034806
    [No Abstract]   [Full Text] [Related]  

  • 13. Modification of The Paris System for urinary tract washing specimens using diagnostic cytological features.
    Suh J; Go H; Sung C; Baek S; Hwang H; Jeong S; Cho Y
    Cytopathology; 2017 Dec; 28(6):516-523. PubMed ID: 28816366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytohistological correlation of urine cytology in a tertiary centre with application of the Paris system.
    Rohilla M; Singh P; Rajwanshi A; Gupta N; Srinivasan R; Dey P; Kakkar N
    Cytopathology; 2018 Oct; 29(5):436-443. PubMed ID: 29920811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of upper urinary tract urine cytology before and after application of the Paris system.
    Simon CT; Skala SL; Magers MJ; Weizer A; Kaffenberger SD; Chinnaiyan AM; Spratt DE; Montgomery J; Mehra R; Lew M
    Diagn Cytopathol; 2019 May; 47(5):421-427. PubMed ID: 30569543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Category of the Johns Hopkins Template Has Higher Risk of Malignancy than the Paris System but the Paris System Is More Applicable for Suspicious Category.
    Celik B; Kavas G
    Acta Cytol; 2023; 67(4):425-433. PubMed ID: 36731438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of urine cytology diagnostic reports before and after the implementation of the Paris System classification system in China.
    Ma C; Zhang L
    Cytopathology; 2020 Sep; 31(5):457-462. PubMed ID: 32246545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.
    Zheng X; Si Q; Du D; Harshan M; Zhang Z; Haines K; Shi W; Chhieng DC
    Cytopathology; 2018 Apr; 29(2):184-188. PubMed ID: 29251368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Paris system classification for urinary cytology in patients under bacillus Calmette-Guerin treatment.
    Moulavasilis N; Stravodimos K; Meletis E; Levis P; Leftheriotis V; Lazaris A; Constantinides C; Mikou P
    Diagn Cytopathol; 2022 Jun; 50(6):289-294. PubMed ID: 35262275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inclusion of nuclear area improves the Paris system for reporting urinary cytology.
    Tanaka S; Naritomi M; Monobe Y; Ariyasu S
    Cytopathology; 2023 Mar; 34(2):106-112. PubMed ID: 36336883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.